Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2015

01-02-2015 | Letter to the Editor

Extensive toxic epidermal necrolysis following brentuximab vedotin administration

Authors: Maria Ilaria Del Principe, Giuseppe Sconocchia, Francesco Buccisano, Mariagiovanna Cefalo, Ambra Di Veroli, Giovanna De Santis, Daniela Nasso, Luca Maurillo, Lucia Anemona, Massimiliano Postorino, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti

Published in: Annals of Hematology | Issue 2/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263:1281–5PubMedCrossRef
2.
Gravante G, Esposito G, Marianetti M, Delogu D, Montone A, Sconocchia G (2006) Toxic epidermal necrolysis in patients with malignancies. Ann Oncol 17:1601–2PubMedCrossRef
3.
Mockenhaupt M (2011) The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 7:803–15PubMedCrossRef
4.
Tamiolakis D, Papadopoulos N, Venizelos J, Lambropoulou M, Tsikouras P, Koutsougeras G, Bolioti S, Tsiapali M, Menegaki M, Kouskoukis C (2005) NCL-CD30 Staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development. Clin Exp Med 5:184–9PubMedCrossRef
5.
Baldo BA (2013) Adverse events to monoclonal antibodies used for cancer therapy. Focus on hypersensitivity responses. OncoImmunology 2: e26333
6.
Wei CY, Ko TM, Shen CY, Chen YT (2012) A recent update of pharmacogenomics in drug-induced severe skin reactions. Drug Metab Pharmacokinet 27:132–41PubMedCrossRef
Metadata
Title
Extensive toxic epidermal necrolysis following brentuximab vedotin administration
Authors
Maria Ilaria Del Principe
Giuseppe Sconocchia
Francesco Buccisano
Mariagiovanna Cefalo
Ambra Di Veroli
Giovanna De Santis
Daniela Nasso
Luca Maurillo
Lucia Anemona
Massimiliano Postorino
Giovanni Del Poeta
Sergio Amadori
Adriano Venditti
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 2/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2148-3

Other articles of this Issue 2/2015

Annals of Hematology 2/2015 Go to the issue

Letter to the Editor

Unusual relapse of an angioimmunoblastic T cell lymphoma 11 years after initial manifestation

Original Article

Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation

Original Article

DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells

Original Article

Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study

Original Article

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

Original Article

Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits